UpStream Bio | SC 13G:超過5%持股股東披露文件-FMR LLC(11.822%),Abigail P. Johnson(11.822%)
UpStream Bio | 10-Q:季度報表
UpStream Bio | 8-K:Upstream Bio報告2024年第三季度財務業績和近期業務亮點
UpStream Bio | SC 13D:超過5%持股股東披露文件
UpStream Bio | SC 13G:超過5%持股股東披露文件-BCLS Fund III Investments, LP(4.3%)
UpStream Bio | 4:持股變動聲明-董事 Chimovits Erez
UpStream Bio | 4:持股變動聲明-董事 ORBIMED ADVISORS LLC
UpStream Bio | SC 13D:超過5%持股股東披露文件-OrbiMed Advisors LLC(8.9%),OrbiMed Capital GP VIII LLC(8.9%)等
UpStream Bio | 4:持股變動聲明-股東 AI Upstream LLC
UpStream Bio | SEC STAFF LETTER:其他
UpStream Bio | 4:持股變動聲明-股東 Wellington Biomedical Innovation Master Investors (Cayman) II L.P.
UpStream Bio | 4:持股變動聲明-董事 Chimovits Erez
UpStream Bio | 4:持股變動聲明-董事 Ruddy Marcella K.
UpStream Bio | 4:持股變動聲明-董事 Fleming Harold Edward
UpStream Bio | 4:持股變動聲明-董事 Beckman Daniella
UpStream Bio | 4:持股變動聲明-董事 Ratcliffe Liam
UpStream Bio | 8-K:重大事件
UpStream Bio | S-8:員工福利計劃證券登記
UpStream Bio | 424B4:募資說明書
UpStream Bio | EFFECT:其他
暫無數據
暫無數據